{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/302826287",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1705499478"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#302826287",
  "code": "EF02.0",
  "source": "http://id.who.int/icd/entity/302826287",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Fat hypertrophy"
  },
  "definition": {
    "@language": "en",
    "@value": "Focal hypertrophy of subcutaneous adipose tissue. It is a common sequela of long-term insulin injection into the skin."
  },
  "relatedEntitiesInPerinatalChapter": [
    "http://id.who.int/icd/entity/1808014996"
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Fat hypertrophy"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Insulin-induced localised fat hypertrophy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1425631631"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Insulin-induced lipohypertrophy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1425631631"
    }
  ]
}